Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of HEPASOF (sofosbuvir 400 mg) vs Sovaldi under fasting conditions
TCTR20180530002Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sofosbuvir in hepatitis C virus infection (2 arms), sponsored by Government Pharmaceutical Organization. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on TCTR20180530002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180530002.